Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) CongressGlobeNewsWire • 06/03/20
Navidea Biopharmaceuticals stock rockets toward 13-month high on heavy volume after update trial dataMarket Watch • 05/22/20
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/15/20
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20
Navidea Biopharmaceuticals' (NAVB) CEO Jed Latkin on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/09/19
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Navidea Biopharmaceuticals (NAVB) CEO Jed Latkin on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19